Alliance Pharma plc (Alliance) is a specialty pharmaceutical company, engaged in the development, marketing and distribution of prescription products. The company is involved in the sale of around 35 acquired and licensed prescription brands to various therapeutic categories. Alliance operates in almost 20 countries across the globe. It is headquartered in Wiltshire, the UK.
In August 2008, the company acquired the brand Pavacol-D from William Ransom & Sons. It is an opioid cough suppressant that is used by diabetics as it is sugar free.The company reported revenues of (British Pounds) GBP 21.76 million during the fiscal year ended December 2008, an increase of 19.39% over 2007. The operating profit of the company was GBP 6.37 million during the fiscal year 2008, an increase of 18,632.35% over 2007. The net profit of the company was GBP 2.51 million during the fiscal year 2008, whereas the company reported a net loss of GBP 3.21 million during 2007.